Abstract: The present invention is directed to a method of administering a meloxicam formulation to a mammalian subject in need thereof including: orally administering to the subject an oral solid dosage form including an amorphous meloxicam-cyclodextrin inclusion complex, where administering the amorphous meloxicam-cyclodextrin inclusion complex results in the subject achieving a Tmax not greater than about 3.0 hours.
Type:
Application
Filed:
September 29, 2015
Publication date:
August 3, 2017
Applicant:
Arissa Pharma Ltd.
Inventors:
Hong Sun, Yan Hu, Yansheng Chen, Luwei Zhao